# Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids

> **NCT04965740** · — · COMPLETED · sponsor: **Empower Research Inc** · enrollment: 102 (actual)

## Conditions studied

- PTSD
- Anxiety
- Anxiety Disorders
- Depression
- Depressive Disorder
- Psychological
- Psychedelic Experiences
- Psychedelic Drug Dependence

## Interventions

- **DRUG:** Cannabis

## Key facts

- **NCT ID:** NCT04965740
- **Lead sponsor:** Empower Research Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-04
- **Primary completion:** 2022-02-04
- **Final completion:** 2022-02-15
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2022-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04965740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04965740, "Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04965740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*